Satellos Bioscience MSLE
NASDAQ MSLE
$8.50 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Satellos Bioscience (MSLE) Other Accumulated Expenses (2024)

Updated

Satellos Bioscience's Other Accumulated Expenses was $14.03 million in the quarter ended Dec 31, 2024.

Analysis

Satellos Bioscience (MSLE) Other Accumulated Expenses (2024) Analysis & Trends

As of Dec 31, 2024, Other Accumulated Expenses at Satellos Bioscience came in at $14.36 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Satellos Bioscience 131.40 Mn 131.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 14.03 Mn
API Access

Satellos Bioscience Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=MSLE&period=max&api_key=YOUR_API_KEY